PHK
GILD icon

Point72 Hong Kong’s Gilead Sciences GILD Stock Holding History

Point72 Hong Kong’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-53,500
Closed -$3.3M – 701
2022
Q3 		$3.3M Buy
53,500
+37,900
+243% +$2.39M 0.12% 222
2022
Q2 		$964K Sell
15,600
-13,200
-46% -$817K 0.04% 539
2022
Q1 		$1.71M Buy
28,800
+25,300
+723% +$1.62M 0.06% 358
2021
Q4 		$254K Sell
3,500
-2,800
-44% -$193K 0.01% 951
2021
Q3 		$440K Sell
6,300
-4,900
-44% -$344K 0.01% 956
2021
Q2 		$771K Buy
11,200
+7,500
+203% +$501K 0.03% 789
2021
Q1 		$239K Sell
3,700
-2,600
-41% -$168K 0.01% 1012
2020
Q4 		$367K Buy
+6,300
New +$380K 0.02% 789

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Hong Kong's GILD Position: Q2 2025 in Review

Point72 Hong Kong sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 79,958 shares — an estimated $8.96M sold.

Point72 Hong Kong first reported a position in GILD in Q4 2014 and held it in 21 quarters. The position peaked at $11.2M in Q4 2024. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Point72 Hong Kong reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 79,958 Gilead Sciences shares in Q2 2025, an estimated $8.96M.
  • Point72 Hong Kong first reported a position in Gilead Sciences in Q4 2014 and held it in 21 quarters.
  • Point72 Hong Kong's Gilead Sciences position peaked at $11.2M in Q4 2024.
  • 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.